Ziff Capital Partners
9
87M
6
1.00
2
0.33
1
- Areas of investment
Summary
In 2015 was created Ziff Capital Partners, which is appeared as VC.
Among the most popular portfolio startups of the fund, we may highlight Platelet BioGenesis. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Ediscovery, Biotechnology.
The fund is generally included in less than 2 deals every year. The high activity for fund was in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Ziff Capital Partners, startups are often financed by Vivo Capital, Viventures, U.S. Department of Defense. The meaningful sponsors for the fund in investment in the same round are Qiming Venture Partners, Nest.Bio Ventures.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 2
- Exits
- 1
- Rounds per year
- 1.00
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (7)
- Pharmaceutical (5)
- Health Care (3)
- Life Science (3)
- Therapeutics (2) Show 12 more
- Investments by region
-
- United States (9)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 1.00
- Avg. company exit year
- 22
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Corner Therapeutics | 18 Apr 2024 | Early Stage Venture | 54M | United States, Massachusetts, Watertown |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.